Back to Search Start Over

Discovery of New Allosteric Modulators of the Urotensinergic System through Substitution of the Urotensin II-Related Peptide (URP) Phenylalanine Residue.

Authors :
Billard E
Hébert TE
Chatenet D
Source :
Journal of medicinal chemistry [J Med Chem] 2018 Oct 11; Vol. 61 (19), pp. 8707-8716. Date of Electronic Publication: 2018 Sep 19.
Publication Year :
2018

Abstract

Urotensin II (UII) and urotensin II-related peptide (URP) are functionally selective, suggesting that these two hormones might play distinct physiological role through different interactions with their cognate receptor UT. Hypothesizing that the Phe <superscript>3</superscript> residue of URP, which is also present in UII, is a key-element of its specific UT activation, we evaluated the impact of its replacement by non-natural amino acids in URP. Each compound was evaluated for its ability to bind UT, induce rat aortic ring contraction, and activate G <subscript>q</subscript> , G <subscript>12</subscript> , and β-arrestin 1 signaling pathways. Such modifications impaired contractile efficacy, reflected by a reduced aptitude to activate G <subscript>12</subscript> in URP but not in the truncated but equipotent UII <subscript>4-11</subscript> . Moreover, we have identified two structurally different UT modulators: [d-Phe(pI) <superscript>3</superscript> ]URP and [Bip <superscript>3</superscript> ]URP, which exert a probe-dependent action against UII and URP. These compounds should help us understand the specific roles of these hormones as well as guide further therapeutic development.

Details

Language :
English
ISSN :
1520-4804
Volume :
61
Issue :
19
Database :
MEDLINE
Journal :
Journal of medicinal chemistry
Publication Type :
Academic Journal
Accession number :
30183282
Full Text :
https://doi.org/10.1021/acs.jmedchem.8b00789